Lafutidine clinical trials
How each study uses lafutidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Lafutidine
- 4
Studies by the year they started
4 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2011 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Boryung Pharmaceutical Co., Ltd (2) · Wuhan Union Hospital, China (1) · Taiho Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Irsogladine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antacids source
- One of H2 blockers source
Studies
Open first, then newest update. How each study uses lafutidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis PatientsCompletedPhase 3Boryung Pharmaceutical Co., LtdNCT01499368Written as Lafutidine
- The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult VolunteersCompletedPhase 1Boryung Pharmaceutical Co., LtdNCT02581696Written as Lafutidine
- Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine TabletsCompletedPhase 1Wuhan Union Hospital, ChinaNCT02658864Written as lafutidine
- Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -CompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00229424Written as Lafutidine
Given beside what is tested · 1 — lafutidine is usual care or a partner of the new treatment
Codes
What other systems call lafutidine · ClinicalTrials.gg INT003660
- MeSH (NLM) C076948lafutidineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 49S4O7ADLCLAFUTIDINE, (+/-)-Confirmed FDA, NLM, Wikidata
- Wikidata Q582556lafutidineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C79117LafutidineOne source FDA
- DrugBank DB12770One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C076948 | lafutidine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 49S4O7ADLC | LAFUTIDINE, (+/-)- | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q582556 | lafutidine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C79117 | Lafutidine | One source FDA |
| DrugBank | DB12770 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.